Carruba M O, Picotti G B, Zambotti F, Mantegazza P
Naunyn Schmiedebergs Arch Pharmacol. 1977 Nov;300(3):227-32. doi: 10.1007/BF00500964.
Mazindol and fenfluramine inhibited in vitro the uptake of 5-HT into rat forebrain synaptosomes, whether the synpatosomes were incubated in vitro with the drugs or obtained from animals pretreated in vitro. Chlorimipramine was also effective in this latter preparation. Dose-response relationships and time course of this effect for the various drugs were determined. Fenfluramine also caused release of 5-HT from preloaded synaptosomes in in vitro incubations. Mazindol did not. Brain 5-HT levels were measured after acute and chronic administration of mazindol, fenfluramine and chlorimipramine. Mazindol had no effect, fenfluramine was active in reducing brain 5-HT concentrations acutely and chlorimipramine only after chronic administration. Therefore, it seems that even a long lasting inhibition of the uptake, such as that induced by mazindol, is not sufficient, per se, to cause depletion of brain 5-HT.
无论突触体是在体外与药物一起孵育,还是取自体外预处理过的动物,马吲哚和芬氟拉明在体外均能抑制5-羟色胺(5-HT)摄入大鼠前脑突触体。氯米帕明在后者的制备中也有效。测定了各种药物的剂量反应关系和这种作用的时间过程。芬氟拉明在体外孵育时还能使预先装载的突触体释放5-HT。马吲哚则不能。在急性和慢性给予马吲哚、芬氟拉明和氯米帕明后,测定了脑内5-HT水平。马吲哚无作用,芬氟拉明能急性降低脑内5-HT浓度,而氯米帕明仅在慢性给药后起作用。因此,似乎即使是像马吲哚所诱导的那样持久的摄取抑制本身也不足以导致脑内5-HT耗竭。